Phase I/II trial of KRN7000 in patients with chronic hepatitis B infection
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Alpha galactosylceramide (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 10 Nov 2006 New trial record.